The Hidden Risks in Life Settlement Underwriting: What Advisors Must Know

Life settlements offer a secondary market option for policy owners—typically seniors aged 65+—to sell their existing life insurance policies for a lump-sum payment exceeding the cash surrender value but below the death benefit. The buyer assumes premium payments and collects the death benefit upon the insured’s passing. This transaction can provide liquidity for retirees facing high premiums or changing needs. However, the underwriting process that determines policy value carries significant hidden risks for financial advisors, estate planners, and their clients.

Advisors recommending or facilitating life settlements must navigate medical underwriting, longevity projections, regulatory compliance, valuation uncertainties, fraud potential, and tax complexities. Missteps can expose clients to financial losses, legal liabilities, or ethical pitfalls, and advisors to professional repercussions. This article explores these risks in depth and offers practical guidance.

Understanding Life Settlement Underwriting

Life settlement underwriting differs from traditional life insurance underwriting. Primary insurers assess applicants for policy issuance based on health to set premiums. In settlements, medical underwriters evaluate an existing policyholder’s life expectancy (LE) to price the policy for secondary market buyers.

The process typically involves:

• Medical record review: Underwriters examine physician notes, lab results, and history.
• Life expectancy reports: Providers issue LE estimates, often in months or years, using actuarial tables adjusted by risk multipliers for conditions like cancer, heart disease, or diabetes.
• Policy valuation: Buyers model net present value considering premiums, expected death benefit timing, and costs.

Underwriting relies on historical data and medical advancements, making it inherently forward-looking yet imperfect. Advisors must understand that LE estimates are probabilistic, not guarantees. A policy projected for a 5-year LE might extend to 10+ years due to new treatments or misestimation.

Longevity Risk: The Core Underwriting Challenge

Longevity risk—the chance the insured outlives projections—is the foremost hidden risk. Buyers pay more premiums and delay the death benefit, eroding returns.

Underwriters use quantitative models based on large datasets or qualitative assessments targeting specific impairments. Both have drawbacks. Quantitative approaches may overlook individual nuances, while qualitative assessments can concentrate risk in certain conditions vulnerable to medical breakthroughs.

Portfolios often experience maturities slower than projected, leading to write-downs. Advisors should scrutinize LE reports from multiple independent underwriters and stress-test scenarios for 20-30% longer lifespans.

Valuation Risks and Model Uncertainty

Valuation integrates LE with policy details (face amount, premium schedule, carrier strength). Hidden risks include:

• Inaccurate inputs or incomplete medical records
• Market volatility and fluctuating liquidity
• Differences between proprietary and standardized valuation models

Carrier risk also remains important — what if the insurer contests the claim or faces financial distress? Advisors must verify policy incontestability and carrier ratings.

Regulatory and Compliance Risks

Life settlements face a patchwork of state regulations. Over 40 states license brokers and providers, with varying disclosure and fiduciary requirements. Variable life policies may also fall under SEC/FINRA oversight.

Key risks for advisors include licensing violations, inadequate disclosures, and exposure to STOLI (Stranger-Originated Life Insurance) transactions, which can void policies.

Fraud and Ethical Pitfalls

The industry has faced issues such as misrepresentation in applications, investment scams, bid-rigging, and undisclosed fees. Advisors must perform proper due diligence to avoid complicity.

Ethical concerns also arise because the new owner has a financial interest in the insured’s death, raising privacy and moral considerations.

Tax Implications: Often Overlooked

According to IRS guidelines, life settlement proceeds are taxed in tiers: tax-free up to the cost basis, then ordinary income up to cash surrender value, with the remainder generally treated as long-term capital gains. Viatical settlements for terminally or chronically ill individuals may qualify for full tax exclusion.

Best Practices for Advisors

1. Stay current with industry trends, underwriting methods, and regulations.
2. Always obtain multiple life expectancy reports.
3. Compare multiple settlement offers through licensed brokers.
4. Thoroughly document client suitability and informed consent.
5. Work with reputable, licensed partners and tax/legal professionals.
6. Provide balanced risk disclosure to clients.
7. Avoid conflicts of interest and disclose all compensation.

Conclusion

Life settlements can transform “dead” policies into living capital, but the underwriting process contains hidden risks including longevity misestimation, valuation errors, regulatory complexity, fraud, and tax consequences. Advisors who approach this market with diligence, proper due diligence, and ethical practices can deliver significant value to clients while protecting their own professional reputation.